Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium

References

• Attama, A.A., Nkemnele, M.O. (2005). In vitro evaluation of drug release from self micro-emulsifying drug delivery systems using a novel biodegradable homolipid from Capra hircus. Int J Pharm. 304:4–10.
   PubMed Web of Science ®Google Scholar
• Attama, A.A., Reichl, S., Müller-Goymann, C.C. (2008). Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm. 355:307–13.
   PubMed Web of Science ®Google Scholar
• Attama, A.A., Schicke, B.C., Paepenmüller, T., Müller-Goymann, C.C. (2007). Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization. Eur J Pharm Biopharm. 67:48–57.
   PubMed Web of Science ®Google Scholar
• Azzi, C., Zhang, J., Purdon, H.C., Chapman, J.N., Nitcheva, D., Herbert, R.J., Smith, W.E. (2006). Permeation and reservoir formulation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene(B[a]P) across porcine esophageal tissue in the presence of ethanol and methanol. Carcinogenesis 27:137–45.
   PubMed Web of Science ®Google Scholar
• Bekerman, T., Golenser, J., Domb, A. (2004). Cyclosporin nanoparticulate lipospheres for oral administration. J Pharm Sci. 93: 1264–70.
   PubMed Web of Science ®Google Scholar
• British Pharmacopoeia. (2001). London: Her Majesty’s Stationery Office. p. 275.
   Google Scholar
• Costas, K. (2006). Recent advances in novel drug delivery system. Azjono J Nanotechnol Online. 2:1–11.
   Google Scholar
• Craig, D.Q.M. (2004). Lipid matrices for sustained release—an academic overview. Bull Tech Gattefossé. 97:9–19.
   Google Scholar
• Didier, L.M. (2000). Rationale and application of lipids as pro-drug carriers. Eur J Pharm Sci. 11:243–55.
   Google Scholar
• Doktorovova, S., Souto, E.B. 2009. Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review. Exp Opin Drug Deliv. 6: 165–76.
   PubMed Web of Science ®Google Scholar
• Domb, A.J. (1993). Lipospheres for controlled delivery of substances. Available online at: freepatentonline.com/5188837.html. Accessed October 10, 2008.
   Google Scholar
• Domb, A.J. (1995). Long acting injectable oxytetracycline-liposphere formulation. Int J Pharm. 124:271–8.
   Web of Science ®Google Scholar
• El-Gibaly I, Abdel-Ghaffar SK. (2005). Effect of hexacosanol on the characteristics of novel sustained-release allopurinol solid lipospheres (SLS): factorial design application and product evaluation. Int J Pharm. 294:33–51.
   PubMed Web of Science ®Google Scholar
• Ellbogen, M.H., Olsen, K.M., Gentry-Nielsen, M.J., Preheim, L.C. (2003). Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia. J Antimicrob Chemother. 51:83–91.
   PubMed Web of Science ®Google Scholar
• Franz, T.J. (1975). Percutaneous absorption- on the relevance of in vitro data. J Invest Dermatol. 64:190–5.
   PubMed Web of Science ®Google Scholar
• Friedrich, I., Reichl, S., Müller-Goymann, C.C. (2005). Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS). Int J Pharm. 305:167–75.
   PubMed Web of Science ®Google Scholar
• Hamidi, M., Azadi, A., Rafiei, P. (2006). Pharmacokinetic consequences of PEGylation. Drug Deliv. 13:399–409.
   PubMed Web of Science ®Google Scholar
• Hassan, M.A., Mohammed, F.A., Sabour, E.A. (2003). Formulation and evaluation of ciprofloxacin hydrochloride and norfloxacin gel. STP Pharma Sci. 13:195–201.
   Google Scholar
• Iannuccelli, V., Coppi, G., Sergi, S., Mezzena, M., Scalia, S. (2008). In vivo and in vitro skin permeation of butyl methoxydibenzoylmethane from lipospheres. Skin Pharmacol Physiol. 21:30–8.
   PubMed Web of Science ®Google Scholar
• Lasic, D.D., Templeton, N.S. (1996). Liposomes in gene therapy. Adv Drug Deliv Rev. 20:221–66.
   Web of Science ®Google Scholar
• Morkhade, D.M., Joshi, S.B. (2007). Evaluation of gum dammar as a novel microencapsulating material for ibuprofen and diltiazem hydrochloride. Indian J Pharm Sci. 67:263–8.
   Google Scholar
• Rabasco, A., Gonzalez, R. (2000). Lipids in pharmaceutical and cosmetics preparation. Coden Gracan. 15:114.
   Google Scholar
• Rocephin®, Drug package insert. Switzerland: Roche.
   Google Scholar
• Ryan, S.M., Mantovani, G., Wang, X., Haddleton, D.M., Brayden, D.J. (2008). Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opin Drug Deliv. 5:1–13.
   PubMedGoogle Scholar
• Sasol. 2008. Softisan® 154, Product information. Available online at: http://www.sasolos.com/products/pdf/excipients_pharmaceuticals.pdf, accessed October 10, 2008.
   Google Scholar
• Shivakumar, H.N., Patel, P.B., Desai, B.G., Ashok, P., Arulmozhi, S. (2007). Design and statistical optimization of glipizide loaded lipospheres using response surface methodology. Acta Pharm. 57:269–85.
   PubMedGoogle Scholar
• Washington, C. (1996). Stability of lipid emulsions for drug delivery. Adv Drug Deliv Rev.20:131–45.
   Web of Science ®Google Scholar
• Westesen, K., Siekmann, B. (1998). Solid lipid nanoparticles of bioactive agent and method for the manufacture and use thereof. United States Patent 5785 976.
   Google Scholar
• Winkler A., Müller-Goymann C.C. (2002). Comparative permeation studies for different formulations enriched with 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum. Arch Pharm Med Chem. 333:67.
   Google Scholar
• Zhang, X., Gan, Y., Nie, S., Pan, W. (2008). PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effect against lung cancer. J Pharm Pharmacol. 60:1077–87.
   PubMed Web of Science ®Google Scholar